Literature DB >> 2591114

Correlation of synovial fluid interleukin 6 (IL-6) activities with IgG concentrations in patients with inflammatory joint disease and osteoarthritis.

E Hermann1, B Fleischer, W J Mayet, T Poralla, K H Meyer zum Büschenfelde.   

Abstract

Synovial fluids of patients with rheumatoid arthritis, osteoarthritis, psoriatic arthritis, reactive arthritis and Reiter's syndrome were examined for their concentrations of interleukin 6 (IL-6) in a proliferation assay with the IL-6 dependent hybridoma cell line B13.29 (subclone B9). IL-6 activity was significantly higher in the synovial fluids of patients with rheumatoid arthritis and psoriatic arthritis than in patients with osteoarthritis. Significant correlations were shown between the concentrations of synovial fluid IL-6 and IgG. These findings may contribute to the understanding of the enhanced immunoglobulin production by synovial mononuclear cells in patients with inflammatory joint disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591114

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  B-cell involvement in the pathogenesis of RA-is there a contribution of the sympathetic nervous system?

Authors:  Georg Pongratz; Rainer H Straub
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice.

Authors:  F A van de Loo; S Kuiper; F H van Enckevort; O J Arntz; W B van den Berg
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

3.  Correlation of anti-cytoskeleton antibody activities in synovial fluid with interleukin-6 in patients with osteoarthritis and inflammatory joint disease.

Authors:  W J Mayet; E Hermann; M Bachmann; M Manns; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1990-07-05

Review 4.  Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense.

Authors:  L Graeve; M Baumann; P C Heinrich
Journal:  Clin Investig       Date:  1993-08

5.  Interleukin-6 in synovial fluid is closely associated with chronic synovitis in rheumatoid arthritis.

Authors:  U Sack; R W Kinne; T Marx; P Heppt; S Bender; F Emmrich
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

6.  Serum IL-4, IL-10 and IL-6 levels in inflammatory arthritis.

Authors:  F M Cicuttini; K A Byron; D Maher; A M Wootton; K D Muirden; J A Hamilton
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

7.  Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters.

Authors:  N Kutukculer; S Caglayan; F Aydogdu
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

8.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

Authors:  M Peters; S Jacobs; M Ehlers; P Vollmer; J Müllberg; E Wolf; G Brem; K H Meyer zum Büschenfelde; S Rose-John
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

9.  Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab.

Authors:  Soamarat Vilaiyuk; Butsabong Lerkvaleekul; Sirisucha Soponkanaporn; Chavachol Setthaudom; Supranee Buranapraditkun
Journal:  Cent Eur J Immunol       Date:  2019-07-30       Impact factor: 2.085

10.  Induction of the interleukin 6/ signal transducer and activator of transcription pathway in the lungs of mice sub-chronically exposed to mainstream tobacco smoke.

Authors:  Sabina Halappanavar; Marsha Russell; Martin R Stampfli; Andrew Williams; Carole L Yauk
Journal:  BMC Med Genomics       Date:  2009-08-21       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.